3-O-methylquercetin more selectively inhibits phosphodiesterase subtype 3

Planta Medica

Volumn 69, Issue 4, 2003, Pages 310-315

  Ko, Wun Chang ^a   Chen, Mei Chun ^a   Wang, Sheng Hao ^a   Lai, Ya Hsin ^a   Chen, Jun Hao ^a   Lin, Chun Nan ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

3 O Methylquercetin; Guinea pig; Isozymes; Phosphodiesterase; Rhamnaceae; Rhamnus nakaharai

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; ISOENZYME; MILRINONE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PLANT MEDICINAL PRODUCT; QUERCETIN 3 METHYL ETHER; SEPHAROSE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; ASTHMA; CHROMATOGRAPHY; DRUG EFFECT; ELUTION; ENZYME INHIBITION; GUINEA PIG; HEART; IC 50; LUNG; MEDICINAL PLANT; NONHUMAN; RHAMNUS; RHAMNUS NAKAHARAI; SUPERNATANT; TRADITIONAL MEDICINE;

ANIMALS; EXONUCLEASES; GUINEA PIGS; INHIBITORY CONCENTRATION 50; ISOENZYMES; LUNG; MALE; MYOCARDIUM; PHYTOTHERAPY; PLANT EXTRACTS; QUERCETIN; RHAMNUS;

ANIMALIA; CAVIA PORCELLUS; RHAMNACEAE; RHAMNUS; SUS SCROFA;

EID: 0037616054     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38874     Document Type: Article

References (20)

1. Giembycz MA. Phosphodiesterase 4 inhibitors and the treatment of asthma. Drugs 2000; 59: 193-212
2. Torphy TJ, Cieslinski LB. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Molecular Pharmacology 1990; 37: 206-14
3. Kapui Z, Schaeffer P, Mikus EG, Boronkay E, Gyürky J, Herbert JM, Pascal M. Experimental studies on guanosine 3′,5′-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265 579 in guinea-pigs. Arzneimittel-Forschung 1999; 49: 685-93
4. De Boer J, Philpott AJ, van Amsterdam RG, Shahid M, Zaagsma J, Nicholson CD. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. British Journal of Pharmacology 1992; 106: 1028-34
5. Silver PJ, Hamel LT, Perrone MH, Bentley RG, Bushover CR, Evans DB. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and air-way smooth muscle. European Journal of Pharmacology 1988; 150: 85-94
6. Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DWP, Torphy TJ. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. Journal of Pharmacology and Experimental Therapeutics 1994; 270: 250-9
7. Chiu NY, Chang KH. The illustrated medicinal plants of Taiwan. 5 Taipei: SMC. 1998. P. 135-6
8. Ko WC, Wang HL, Lei CB, Shih CH, Chung MI, Lin CN. Mechanisms of relaxant action of 3-O-methylquercerin in isolated guinea pig trachea. Planta Medica 2002; 68: 30-5
9. Lin CN, Lu CM, Lin HC, Ko FN, Teng CM. Novel antiplatelet naphthalene from Rhamnus nakaharai. Journal of Natural Products 1995; 58: 1934-40
10. Thompson WJ, Appleman MM. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 1971; 10: 311-6
11. Ahn HS, Crim W, Romano M, Sybertz E, Pitts B. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochemical Pharmacology 1989; 38: 3331-9
12. Mery PF, Pavoine C, Pecker F, Fischmeister R. erythro-9-(2-Hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Molecular Pharmacology 1995; 48: 121-30
13. Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, Beavo JA. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Molecular Pharmacology 1986; 29: 506-14
14. Sheppard H, Wiggan G, Tsien WH. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Advances in Cyclic Nucleotide Research 1972; 1: 103-12
15. Gillespie PG, Beavo JA. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948. Molecular Pharmacology 1989; 36: 773-81
16. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Chemistry 1976; 72: 248-54
17. Wei BL, Lu CM, Tsao LT, Wang JP, Lin CN. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rharnnus species. Planta Medica 2001; 67: 745-7
18. Cimanga K, Ying L, De Bruyne T, Apers S, Cos P, Hermans N, Bakana P, Tona L, Kambu K, Kalenda DT, Pieters L, Vanden Berghe D, Vlietinck AJ. Radical scavenging and xanthine oxidase inhibitory activity of phenolic compounds from Bridelia ferruginea stem bark. Journal of Pharmacy and Pharmacology 2001; 53: 757-61
19. Laekeman GM, Claeys M, Rwangabo PC, Herman AG, Vlietinck AJ, Cardiovascular effects of 3-methylquercetin. Planta Medica 1986; 6: 433-7
20. Vrijsen R, Everaert L, Van Hoof LM, Vlietinck AJ, Vanden Berghe DA, Boeye A. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Research 1987; 7: 35-42